Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 14,046 shares at $79.87 ($1.1M) on 2020-11-05, disclosed to the SEC on 2020-11-06.
Open-market sale of $1.1M MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.89 | 3,434 | $274K | 24.5% |
| 2 | $79.89 | 3,434 | $274K | 24.5% |
| 3 | $79.87 | 3,589 | $287K | 25.5% |
| 4 | $79.87 | 3,589 | $287K | 25.5% |
| Total | $79.88 avg | 14,046 | $1.1M | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |
| MGLN | SELL | 2019-12-11 | $2.6M | — | Filing → |